Cemiplimab-rwlc Approved in Advanced Cutaneous Squamous Cell Carcinoma

被引：0
|
作者：
Schuyler, Devon
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2018年 / 16卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：707 / 707
页数：1
相关论文
共 50 条
  • [31] Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme
    Garcia Castano, A.
    Munoz Couselo, E.
    Soria, A.
    Lavernia, J.
    Sanmartin, O.
    Canueto, J.
    Ayala de Miguel, P.
    Bea Ardebol, S.
    Bellido Hernandez, L.
    Fernandez-de-Misa Cabrera, R.
    Cunquero-Tomas, A. J.
    Fernandez Franco, L.
    Fernandez-Freire Leal, A.
    Mujika Eizmendi, K.
    Ortiz, C.
    Redondo, P.
    Romero, I.
    Serrano Fernandez, M.
    Medina Martinez, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S884 - S884
  • [32] Novel treatment of locally advanced cutaneous squamous cell carcinoma with cemiplimab: a case report
    Nelson, Rachel
    Luu, Ly
    Silberstein, Peter
    Velagapudi, Manasa
    Huerter, Christopher
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (02) : 233 - 235
  • [33] Radiation recall during cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma
    Vaccaro, Mario
    Bertino, Lucrezia
    Santarpia, Mariacarmela
    Altavilla, Giuseppe
    Cannavo, Serafinella P.
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [34] Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
    Baggi, Alice
    Quaglino, Pietro
    Rubatto, Marco
    Depenni, Roberta
    Guida, Michele
    Ascierto, Paolo Antonio
    Trojaniello, Claudia
    Queirolo, Paola
    Saponara, Maristella
    Peris, Ketty
    Spagnolo, Francesco
    Bianchi, Luca
    De Galitiis, Federica
    Potenza, Maria Concetta
    Proietti, Ilaria
    Marconcini, Riccardo
    Botticelli, Andrea
    Barbieri, Vito
    Licitra, Lisa
    Alfieri, Salvatore
    Ficorella, Corrado
    Cortellini, Alessio
    Fargnoli, Maria Concetta
    Troiani, Teresa
    Tondulli, Luca
    Bossi, Paolo
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 250 - 258
  • [35] CEMIPLIMAB FOR THE TREATMENT OF ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA IN ITALY: A BUDGET IMPACT ANALYSIS
    Ghetti, G.
    D'Avella, M. C.
    Pradelli, L.
    VALUE IN HEALTH, 2020, 23 : S440 - S440
  • [36] Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma
    Mallardo, Domenico
    Sparano, Francesca
    Vitale, Maria Grazia
    Trojaniello, Claudia
    Fordellone, Mario
    Cioli, Eleonora
    Esposito, Assunta
    Festino, Lucia
    Mallardo, Mario
    Vanella, Vito
    Facchini, Bianca Arianna
    De Filippi, Rosaria
    Meinardi, Paolo
    Ottaviano, Margaret
    Caraco, Corrado
    Simeone, Ester
    Ascierto, Paolo Antonio
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (08)
  • [37] Simultaneous response of cutaneous and lung squamous cell carcinoma with cemiplimab
    Escobar, Gabriela Fortes
    Granel-Brocard, Florence
    Schmutz, Jean-Luc
    Cervantes, Pierre
    Ben Mahmoud, Sinan
    Bursztejn, Anne-Claire
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [38] Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma
    Geidel, Glenn
    Adam, Laura
    Ruenger, Alessandra
    Menz, Anne
    Koett, Julian
    Haalck, Thomas
    Gebhardt, Christoffer
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1414 - E1416
  • [39] Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios
    Akhtar, Komal
    Sravanthi, Metlapalli Venkata
    D'Angelo, Josephine
    Sivapiragasam, Abirami
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2022, 10
  • [40] PD-1 Blockade with Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma
    Gellrich, F. F.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 73 - 73
12345